These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2792558)

  • 21. Calcitonin and treatment of osteoporosis.
    Rico H
    J Med; 1985; 16(4):493-5. PubMed ID: 3913727
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of severe postmenopausal osteoporosis].
    Reĭsner NA; Babarykin DA; Vorona IG; Riabukha AN; Rozental' RL
    Probl Endokrinol (Mosk); 1988; 34(4):13-6. PubMed ID: 3194355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
    Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
    N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts in the treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ
    Postgrad Med; 1972 Oct; 52(4):62-7. PubMed ID: 5070959
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G
    Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
    Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
    J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX; Li H
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of primary osteoporosis with calcium and salmon calcitonin].
    Ringe JD
    Dtsch Med Wochenschr; 1990 Aug; 115(31-32):1176-82. PubMed ID: 2199180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gelatin microspheres containing calcitonin gene-related peptide or substance P repair bone defects in osteoporotic rabbits.
    Chen J; Liu W; Zhao J; Sun C; Chen J; Hu K; Zhang L; Ding Y
    Biotechnol Lett; 2017 Mar; 39(3):465-472. PubMed ID: 27909823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
    J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcitonin and calcium medication in treatment of edentulous osteoporotic mandible.
    Postic SD
    Vojnosanit Pregl; 2013 Jun; 70(6):576-9. PubMed ID: 23885524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.
    Hesch RD; Busch U; Prokop M; Delling G; Rittinghaus EF
    Calcif Tissue Int; 1989 Mar; 44(3):176-80. PubMed ID: 2493323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The concept and treatment of osteoporosis.
    Rittinghaus EF; Hesch RD; Harms HM; Busch U; Prokop M; Delling G
    Exp Gerontol; 1990; 25(3-4):357-65. PubMed ID: 2226671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosis.
    Jackson EC; Strife CF; Tsang RC; Marder HK
    Am J Dis Child; 1988 Nov; 142(11):1237-9. PubMed ID: 3177335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacologic therapy of osteoporosis].
    Kushida K
    Nihon Rinsho; 1994 Sep; 52(9):2367-77. PubMed ID: 7967083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin on osteoporotic bone fragility.
    Fujita T
    Calcif Tissue Int; 1990 Oct; 47(4):256. PubMed ID: 2242498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.